Artelo Biosciences, a Nasdaq-listed company, has announced the sale of 3,188,407 shares of common stock at $3.45 per share through a private placement, raising a total of $11 million. According to Foresight News, the newly acquired funds will be allocated for general corporate purposes and to repay some transitional debt. Recent data from StrategicSolanaReserve indicates that Artelo currently holds 45,883 SOL.